Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Bioventus (BVS) Cost of Revenue (2020 - 2026)

Bioventus filings provide 6 years of Cost of Revenue readings, the most recent being $49.1 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 3.66% to $49.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $179.9 million, a 2.77% decrease, with the full-year FY2025 number at $179.9 million, down 2.77% from a year prior.
  • Cost of Revenue hit $49.1 million in Q4 2025 for Bioventus, up from $44.4 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $51.6 million in Q4 2022 to a low of $22.2 million in Q2 2021.
  • Median Cost of Revenue over the past 5 years was $44.3 million (2022), compared with a mean of $42.9 million.
  • Biggest five-year swings in Cost of Revenue: surged 89.63% in 2021 and later decreased 9.0% in 2024.
  • Bioventus' Cost of Revenue stood at $42.6 million in 2021, then rose by 21.1% to $51.6 million in 2022, then decreased by 4.89% to $49.1 million in 2023, then grew by 3.79% to $51.0 million in 2024, then fell by 3.66% to $49.1 million in 2025.
  • The last three reported values for Cost of Revenue were $49.1 million (Q4 2025), $44.4 million (Q3 2025), and $45.6 million (Q2 2025) per Business Quant data.